Although the mechanism of C4a variation in HCV carriers has not been elucidated, our study suggests that serum C4a levels in HCV carriers with PNALT should be dominantly affected by post-translational mechanisms, but patients with CHC may be affected by both translational (downregulation) and post-translational (upregulation) mechanisms. This evidence concerns the gene C4A and cryohydrocytosis.